AIM ImmunoTech, Inc. (AIM)
1.49
+0.11
(+7.97%)
USD |
NYAM |
Dec 08, 16:00
1.49
0.00 (0.00%)
After-Hours: 16:49
AIM ImmunoTech Shareholders Equity (Quarterly): -6.077M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | 242.22M |
| Protalix Biotherapeutics, Inc. | 52.91M |
| Electromed, Inc. | 44.74M |
| Xtant Medical Holdings, Inc. | 50.38M |
| Armata Pharmaceuticals, Inc. | -95.59M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.494M |
| Total Liabilities (Quarterly) | 11.57M |
| Debt to Equity Ratio | -0.3847 |
| Current Ratio | 0.6369 |
| Net Debt Paydown Yield | 9.75% |